Abstract
Protein kinase CK2 has long been known to be involved in cell growth and proliferation. Recent work has also implicated its role in the suppression of apoptosis. We originally documented that removal of survival or growth stimuli resulted in rapid loss of CK2 from the nuclear matrix and chromatin which preceded induction of apoptosis. Further, we demonstrated that overexpression of CK2 in cells promotes suppression of drug-mediated apoptosis. In the present work, we have extended these observations to demonstrate that CK2 can influence apoptosis mediated via the death receptors. Overexpression of CK2 resulted in suppression of apoptosis mediated by TNF-α, TRAIL, and Fas-L in cells responsive to these ligands, whereas downregulation of CK2 resulted in augmentation of apoptosis mediated by these ligands. To our knowledge, this is the first report to show that receptor-mediated apoptosis can be modulated by changes in CK2 in prostate cancer cells. Based on our previous observations together with the evidence presented here, we propose that CK2 has an impact on the process of apoptosis mediated by diverse type of mechanisms thus playing a global role in regulation of apoptotic activity in cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CK2:
-
acronym for the former name casein kinase 2
- TBB:
-
tetrabromobisbenzamide
References
Guerra B, Issinger O-G: Protein kinase CK2 and its role in cellular proliferation, development and pathology. Electrophoresis 20: 391–408, 1999
Tawfic S, Yu S, Wang H, Faust R, Davis A, Ahmed K: Protein kinase CK2 signaling in neoplasia. Histol Histopathol 16: 573–582, 2001
Ahmed K, Gerber D, Cochet C: Joining the cell survival squad: An emerging role for protein kinase CK2. Trends Cell Biol 12: 226–230, 2002
Pinna LA: Protein kinase CK2 – a challenge to canons. J Cell Sci 115: 3873–3878, 2002
Litchfield DW: Protein kinase CK2: Structure, regulation, and role in cellular decisions of life and death. Biochem J 369: 1–15, 2003
Guo C, Yu S, Davis AT, Green JE, Ahmed K: A potential role of nuclear matrix-associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. J Biol Chem 276: 5992–5999, 2001
Yu S, Wang H, Davis A, Ahmed K: Consequences of CK2 signaling to the nuclear matrix. Mol Cell Biochem 227(1/2): 67–71, 2001
Evans G, Vousden K: Proliferation, cell cycle, and apoptosis in cancer. Nature 411: 342–348, 2001
Ahmed K: Nuclear matrix and protein kinase CK2 signaling. Critical Rev Eukaryotic Gene Expression. 9: 329–336, 1999
Wang H, Davis A, Yu S, Ahmed K: Response of cancer cells to molecular interruption of the CK2 signal. Mol Cell Biochem 227: 167–74, 2001
Ruzzene M, Penzo D, Pinna L: Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. Biochem J 364: 41–47, 2002
Pyerin W, Ackermann K: Transcriptional coordination of the genes encoding catalytic (CK2α) and regulatory (CK2β) subunits of human protein kinase CK2. Mol Cell Biochem 227: 45–57, 2001
Landesman-Bollag E, Song DH, Romieu-Mourez R, Sussman DJ, Cardiff RD, Sonenshein GE, Seldin DC: Protein kinase CK2: Signaling and tumorigenesis in the mammary gland. Mol Cell Biochem 227: 175–183, 2001
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wang, G., Ahmad, K.A. & Ahmed, K. Modulation of death receptor-mediated apoptosis by CK2. Mol Cell Biochem 274, 201–205 (2005). https://doi.org/10.1007/s11010-005-2952-0
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-2952-0